Why are clinical trials struggling with diversity?
pharmaphorum
MAY 26, 2022
The race to produce a vaccine which could protect the world against COVID-19 brought the topic of diversity in clinical trials, or lack of it, into sharp focus. Vaccines approved for public use require comprehensive RCTs to establish their safety and efficacy. The pandemic brought imbalances into sharp focus.
143 
Let's personalize your content